This website uses cookies to ensure you get the best experience on our website.
Read more
Ok, got it!
Svenska
About Investor
Our Investments
Investors & Media
Your Career
Contact Us
Menu
About Investor
Our Investments
Investors & Media
Sub navigation
Reports
Press Releases
Presentations
CMD 2017
The Investor movie
Investor Talks 2016
2017
2016
2015
2014
2013
2012
Archive
Share Information
Total Shareholder Return
Dividend and dividend policy
Dividend
Ownership Structure
Repurchase of own shares
Historical share data
Analysts
Investor in Figures
Key Figures
Financial Statements
Accounting Policies
Accounting and Valuation of holdings
Equity-related investments
Definitions
Risks and Risk Management
Commercial Risks
Financial Risks
Operational Risks
Legal and Regulatory risks
Treasury
Rating information
Maturity Profile
Leverage policy
Loan Programs and Facilities
Outstanding Public Bonds
Investor and Media Services
Share price calculator
Tax Assistance
Subscription services
Order printed information
Newsroom
Comments
Investor informs – position on number of board assignments
Investor comments on reportings in the media concerning the costs of the party in connection with our 100 year celebration
Investor comments on ABB’s strategic review of the Power Grids division
Investor's trading position in Scania
Investor comments the article in SvD Näringsliv November 12, 2013
Vårdapoteket - development during Investor Growth Capital's ownership
Clarification regarding the Board of Director's annual compensation for 2012
Information regarding the inaccurate disclosure in Biotage/Active Biotech
Investor's relation to EQT
Investor has equal salaries - comment on article "DO synar finansen" in SvD, January 23, 2013
Q&A on the discount to net asset value
Investor's financing and ambition for core investment Aleris
Answers for Patricia Hedelius questions for Börje Ekholm in Svenska Dagbladet 10/17/11
CEO Börje Ekholms response to shareholder Daniel Swärd's letter regarding Investor's NAV discount 2/8/11
Trading results 2007-2011
CEO's opening speech for extraordinary General Meeting for Carmel Pharma
CEOs letter to the shareholders of Carmel Pharma
Investor Growth Capital's involvement in AirPlusTV/Dahlia
Clarification regarding CEO remuneration
CEO Remuneration 2005-2010
Jacob Wallenberg - full compilation of engagements
Complete interview with Jacob Wallenberg which was only published in part in Dagens Industri 01/25/11
Complete interview with Jacob Wallenberg and questions for Investor which was only published in part in Svenska Dagbladet 01/25/11
Notices
Events calendar
Events calendar archive
Image gallery
Board of Directors
Management Group
Logotypes
Close
